Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT04734626

CrCest Study in Primary Mitochondrial Disease

Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
230 (estimated)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
7 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to perform a "muscle phenotyping" magnetic resonance imaging (MRI) assessment in patients receiving clinical care at the Children's Hospital of Philadelphia (CHOP) for mitochondrial disease that is either suspected (based on clinical presentation) or has a definite genetic diagnosis. The MRI assessment quantifies skeletal muscle oxidative phosphorylation (OXPHOS) capacity. Investigators hope that this study will contribute to our current knowledge of mitochondrial diseases and this study will help create a new diagnostic tool for use in both clinical care and in clinical trials.

Detailed description

This research study visit will occur on the same day as the participants clinically scheduled MRI. The clinically indicated and study-specific scanning time will not exceed 120 minutes. During the study visits: * A study team member will review inclusion and exclusion criteria with the participant * A study team member will review medical history review with the participant * A safety assessment will occur prior to study procedures * Study MRI scan * During which the participant will use an MRI-safe machine to stimulate exercise, similar to pressing a gas pedal If eligible participants return to CHOP for future clinical imaging, we will also request a study-specific MRI assessment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCreatine Chemical Exchange Saturation Transfer (CrCEST) Imaging SequenceCrCEST be used to assess creatine distribution and concentrations in muscle (lower extremity), both at rest and after recovery from a brief foot-pedal depression exercise

Timeline

Start date
2021-05-25
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2021-02-02
Last updated
2026-01-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04734626. Inclusion in this directory is not an endorsement.